← All companies

Owkin

Healthcare & Life Sci

Company overview

Owkin builds AI technology that automates biopharmaceutical research and development and supports clinical research. Its customers are pharmaceutical and biopharma companies. K Pro, its main product, is an AI agent that connects research data with patient care to help drug companies make decisions. Owkin is based in Paris.

Thomas Clozel and Gilles Wainrib founded Owkin on August 3, 2016. The company raised over $308 million and became a unicorn in November 2021, when Sanofi invested $180 million. Owkin has about 250 employees projected for 2026. A major drug maker betting $180 million on Owkin's AI shows how seriously pharma takes automated research.

Currently, there's a total of 5 job openings at Owkin. Over the last 30 days, 6 jobs were added and 1 was removed.

Industry
Healthcare & Life Sci
Headquarters
Paris, France

Filters

Create your account

Create an account to save jobs and track applications.